Detalles de la búsqueda
1.
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review.
J Alzheimers Dis
; 77(3): 1181-1194, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32925028
2.
Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia.
JAMA Netw Open
; 3(4): e203630, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343351
3.
Institutionalization risk and costs associated with agitation in Alzheimer's disease.
Alzheimers Dement (N Y)
; 5: 851-861, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31799369
4.
The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies.
Int Clin Psychopharmacol
; 33(5): 255-260, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29878915
5.
The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review.
Front Psychiatry
; 8: 42, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28367128
Resultados
1 -
5
de 5
1
Próxima >
>>